Clinical trial
Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or…
NCT00336063 · National Cancer Institute (NCI), NIH · Active, not recruiting
Key facts
| NCT number | NCT00336063 |
|---|---|
| Title | Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma |
| Official title | A Phase I Trial of 5Azacitidine and Suberoylanilide Hydroxamic Acid in Patients With Metastatic or Locally Recurrent Nasopharyngeal Carcinoma and Nasal NK-T Cell Lymphoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Active, not recruiting |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Adult Nasal Type Extranodal NK/T-Cell Lymphoma, Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma, Recurrent Nasopharyngeal Undifferentiated Carcinoma, Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7 |
| Intervention type | Drug, Other |
| Interventions | Azacitidine, Laboratory Biomarker Analysis, Pharmacological Study, Vorinostat |
| Enrollment | 18 |
| Start date | Mar 3, 2006 |
| Primary completion | Apr 19, 2013 |
| Completion | Mar 19, 2026 |
| First posted | Jun 12, 2006 |
| Last update posted | Aug 20, 2025 |
| Countries | Hong Kong, Japan, Singapore, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: